# Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event

> **NCT07499128** · NA · NOT_YET_RECRUITING · sponsor: **National Cancer Institute (NCI)** · enrollment: 136 (estimated)

## Conditions studied

- Cytokine Release Syndrome
- Neoplasms
- Lymphoma
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Multiple Myeloma
- Lymphoma Mantle-cell
- Immunotherapy
- Cell and Tissue-Based Therapy
- Cytokines
- Monitoring Physiologic
- Immune Monitoring
- Wearable Electronic Devices
- Thermometry
- Body Temperature
- Antibodies Bispecific
- Receptors Chimeric Antigen

## Interventions

- **DEVICE:** TempTraq
- **DEVICE:** VitalTraq

## Key facts

- **NCT ID:** NCT07499128
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-21
- **Primary completion:** 2029-06-30
- **Final completion:** 2029-08-18
- **Target enrollment:** 136 (ESTIMATED)
- **Last updated:** 2026-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07499128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07499128, "Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT07499128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*